Search

everythinglearnresearchcommunity

for

Search:↓

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Different types of resting melanocyte stem cells have unique characteristics and vary in their potential to become other cells.

Epidermal stem cells don't use gap junctions to communicate.

Hair follicle stem cells might help treat traumatic brain injury.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Antibodies help identify glycoproteins in normal skin and tumor cells.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

RNase L hinders hair growth by altering immune signals.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Hair follicle stem cells can turn into various cell types and help repair nerves.

Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.

CD34 marks potential stem cells in dog hair follicles.

FOXN1 gene variants cause low T cells and immune issues from birth.

CD34+ hair follicle stem cells can become melanin-producing cells for treating skin conditions.

Deleting the CD271 gene in mouse skin cells leads to disorganized skin and increased hair growth, suggesting CD271 is important for skin health.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Immune cells called Treg cells are essential for hair growth and regeneration.

Basal cell carcinomas may use IDO to protect themselves from the immune system.